Carl Walkey Net Worth & Insider Trades
Carl Walkey - Senior Vice President, Neoleukin Therapeutics, Inc
What is Carl Walkey's Net Worth?
The current estimated net worth of Neoleukin Therapeutics, Inc's Senior Vice President, Carl Walkey, is estimated to be about $1.91M . Carl Walkey owns about 1,352,489 units of Neoleukin Therapeutics, Inc common stock. In the last year at Neoleukin Therapeutics, Inc, Carl Walkey has sold an estimated value of $425.64K worth.
What is Carl Walkey's Past Insider Trading?
Carl Walkey's largest sale order was 3,000 units , worth over $42.6K on February 12, 2021. In total, Carl Walkey has made about 28 transactions over a year of their time at Neoleukin Therapeutics, Inc. Carl Walkey usually trades in April and February, with the busiest year in 2021. The most recent transaction was a sale order of 600 units , worth over $6.11K on June 17, 2021.
Carl Walkey
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Carl Walkey's' Mailing Address?
- Mailing address is C/o Neoleukin Therapeutics, Inc. 360-1616 Eastlake Avenue East Seattle WA 98102 WA
Neoleukin Therapeutics, Inc Executive Compensation
Name |
Year
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|
| Jonathan DrachmanJonathan Drachman | 2020 | $4,468,538 | $4,468,538 | $4,468,538 | - | $4,468,538 |
| Jonathan DrachmanJonathan Drachman | 2019 | $3,823,038 | $3,823,038 | $3,823,038 | - | $3,823,038 |
| Robert Ho | 2020 | $2,654,271 | $2,654,271 | $2,654,271 | - | $2,654,271 |
| Holly Vance | 2020 | $2,091,819 | $2,091,819 | $2,091,819 | - | $2,091,819 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1404644/000119312521102235/d129921ddef14a.htm
What are Neoleukin Therapeutics, Inc's Past Insider Trades?
Neoleukin Therapeutics, Inc's most recent insider trade came on August 12, 2022 by Sean Smith who sold 1,655 units worth $1.64K . In the last 14 years, insiders at Neoleukin Therapeutics, Inc have sold an estimated value of $725.74K and bought an estimated value of $37.07M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Carl Walkey, Senior Vice President, Daron Evans, Chief Financial Officer, and Joshua A Kazam, President & CEO .
Neoleukin Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||